MétaCan
Menu
Back to cohort
Record W2492016132 · doi:10.1111/all.12987

A dual Cys<scp>LT</scp><sub>1/2</sub> antagonist attenuates allergen‐induced airway responses in subjects with mild allergic asthma

2016· article· en· W2492016132 on OpenAlexaff
Gail M. Gauvreau, L.‐P. Boulet, J. Mark FitzGerald, Donald W. Cockcroft, Beth E. Davis, Richard Leigh, Masaya Tanaka, J. Fourre, Toshiya Nabata, Paul M. O’Byrne

Bibliographic record

VenueAllergy · 2016
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsUniversity of CalgaryUniversity of SaskatchewanUniversity of British ColumbiaInstitut universitaire de cardiologie et de pneumologie de QuébecMcMaster University
FundersOno Pharmaceutical
KeywordsMedicineAllergenAsthmaImmunologyMontelukastEosinophilPlaceboBronchospasmSputumAllergyAirwayAnesthesiaPathology

Abstract

fetched live from OpenAlex

Abstract Background The cysteinyl leukotrienes (cys LT s) play a key role in the pathophysiology of asthma. In addition to functioning as potent bronchoconstrictors, cys LT s contribute to airway inflammation through eosinophil and neutrophil chemotaxis, plasma exudation, and mucus secretion. We tested the activity of the dual cys LT 1/2 antagonist, ONO ‐6950, against allergen‐induced airway responses. Methods Subjects with documented allergen‐induced early ( EAR ) and late asthmatic response ( LAR ) were randomized in a three‐way crossover study to receive ONO ‐6950 (200 mg) or montelukast (10 mg) or placebo q.d. on days 1–8 of the three treatment periods. Allergen was inhaled on day 7 two hours postdose, and forced expiratory volume in 1 s ( FEV 1 ) was measured for 7 h following challenge. Sputum eosinophils and airway hyperresponsiveness were measured before and after allergen challenge. The primary outcome was the effect of ONO ‐6950 vs placebo on the EAR and LAR . Results Twenty‐five nonsmoking subjects with mild allergic asthma were enrolled and 20 subjects completed all three treatment periods per protocol. ONO ‐6950 was well tolerated. Compared to placebo, ONO ‐6950 significantly attenuated the maximum % fall in FEV 1 and area under the % FEV 1 /time curve during the EAR and LAR asthmatic responses ( P &lt; 0.05) and allergen‐induced sputum eosinophils. There were no significant differences between ONO ‐6950 and montelukast. Conclusions Attenuation of EAR , LAR , and airway inflammation is consistent with cys LT 1 blockade. Whether dual cys LT 1/2 antagonism offers additional benefit for treatment of asthma requires further study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.446
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.244
Teacher spread0.229 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations23
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueAllergySame topicAsthma and respiratory diseasesFrench-language works237,207